nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity
|
Garrido, Cristina |
|
2009 |
59 |
1 |
p. 13-26 |
artikel |
2 |
Calicum microdomains form within neutrophils at the neutrophil–tumor cell synapse: role in antibody-dependent target cell apoptosis
|
Clark, Andrea J. |
|
2009 |
59 |
1 |
p. 149-159 |
artikel |
3 |
Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancer
|
Gomes, Clarissa P. C. |
|
2009 |
59 |
1 |
p. 173-181 |
artikel |
4 |
Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth
|
Liang, Pei-he |
|
2009 |
59 |
1 |
p. 93-101 |
artikel |
5 |
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
|
Radojcic, Vedran |
|
2009 |
59 |
1 |
p. 137-148 |
artikel |
6 |
Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells
|
Saxena, Ankit |
|
2009 |
59 |
1 |
p. 125-135 |
artikel |
7 |
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen
|
Karyampudi, Lavakumar |
|
2009 |
59 |
1 |
p. 161-171 |
artikel |
8 |
Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide
|
Hendrickson, Ronald C. |
|
2009 |
59 |
1 |
p. 113-124 |
artikel |
9 |
Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide
|
Hendrickson, Ronald C. |
|
|
59 |
1 |
p. 113-124 |
artikel |
10 |
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
|
Szczepanski, Miroslaw J. |
|
2009 |
59 |
1 |
p. 73-79 |
artikel |
11 |
Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma
|
Lladser, Alvaro |
|
2009 |
59 |
1 |
p. 81-92 |
artikel |
12 |
Killer dendritic cells and their potential for cancer immunotherapy
|
Larmonier, Nicolas |
|
2009 |
59 |
1 |
p. 1-11 |
artikel |
13 |
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice
|
Abe, Fuminori |
|
2009 |
59 |
1 |
p. 47-62 |
artikel |
14 |
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
|
Cereda, Vittore |
|
2009 |
59 |
1 |
p. 63-71 |
artikel |
15 |
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells
|
Smits, Evelien L. J. M. |
|
2009 |
59 |
1 |
p. 35-46 |
artikel |
16 |
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome
|
Venanzi, Franco Maria |
|
2009 |
59 |
1 |
p. 27-34 |
artikel |
17 |
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells
|
Bosch, Jacobus J. |
|
2009 |
59 |
1 |
p. 103-112 |
artikel |